急性脑梗死行尤瑞克林联合依达拉奉治疗的疗效及对CRP的动态影响.docVIP

急性脑梗死行尤瑞克林联合依达拉奉治疗的疗效及对CRP的动态影响 　　摘要：目的 分析急性脑梗死行尤瑞克林联合依达拉奉治疗的效果及对CRP动态影响。方法 回顾性分析2009年11月～2014年11月本院收治的60例急性脑梗死患者临床资料，按不同治疗方案分两组，每组各30例。行常规治疗者设对照组，于对照组基础上加用尤瑞克林、依达拉奉治疗者设研究组，对比两组疗效及CRP变化。结果 研究组治疗总有效率高于对照组，差异有统计学意义（P0.05），治疗后CRP水平呈现下降，研究组下降幅度大于对照组，差异具统计学意义（P0.05）。结论 急性脑梗死行尤瑞克林联合依达拉奉治疗可改善患者神经功能，并在降低CRP水平基础上促进患者预后改善。 　　关键词：急性脑梗死；尤瑞克林；依达拉奉；疗效；CRP 　　Effect of Yurek Lin Combined with Edaravone in Treatment of Acute Cerebral Infarction and the Influence of CRP 　　MU Dao-qiang 　　（Changsha Rongcheng Hospital，Changsha 410119，Hunan，China） 　　Abstract：Objective The analysis of efficacy and dynamic influence for CRP that urinary kallidinogenase combined with edaravone on acute cerebral infarction.Methods The clinical data of 60 cases with acute cerebral infarction from November 2009 to November 2014 in this hospital were analysed retrospectively， according to different therapeutic schedule，it divided into two groups，30 cases for each group.The cases with conventional treatments acted as comparison group，The cases with treatments of urinary kallidinogenase combined with edaravone based on comparison group acted as a group for research，Compared the efficacy and change of CRP for these two groups.Results The researchful group have higher efficiency than the comparison group，the difference have statistical significance（P0.05）， the level of CRP took on a descenting situation .the declining range for researchful group was greater than the comparison group，the difference have statistical significance（P0.05）. Conclusion The treatment of urinary kallidinogenase combined with edaravone on acute cerebral infarction can improve patients neurological function and promote their improvement after cure based on declining the CRP level 　　Key words：Acute cerebral infarction；Urinary kallidinogenase；Edaravone；Therapeutic effect；CRP 　　急性脑梗死发病率与病死率均较高，临床治疗关键在于改善或恢复缺血脑组织灌注以避免再损伤[1]。本次通过回顾性分析60例患者临床资料，以分析急性脑梗死行尤瑞克林联合依达拉奉治疗的疗效及对CRP（超敏C反应蛋白）的动态影响，报告如下。 　　1资料与方法 　　1.1一般资料 回顾性分析2009年11月～2014年11月